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Abstract
We planned to determine the clinical utility and safety
of mediastinoscopy in the pathologic diagnosis of
mediastinal lymphadenopathy and to determine
disease patterns in a tertiary care setting in Karachi.
The retrospective review comprised record of patients
who underwent mediastinoscopy over 25 years
between July, 1990 and August, 2015. Of the 122
patients, records were complete for 88(72%). Mean
age was 42.5±12.9 years and 55(62.5%) were male.
Overall, 60(68.2%) patients had benign inflammatory
diseases; 25 (28.4%) had lymphoma or lung cancer
which was accurately staged; 26(29.5%) had
tuberculosis; 13(14.8%) sarcoidosis; and 11 (12.5%)
had concomitant tuberculosis and sarcoidosis. No
mortality or significant morbidity was recorded.
Mediastinoscopy was useful in staging bronchogenic
carcinoma and influenced the management in this
series. It was found to be accurate in the diagnosis of
other malignant as well as benign mediastinal
pathologies, all of which were treatable.
Keywords: Cervical mediastinoscopy, Lymphadenopathy,
Inflammatory diseases, Malignant diseases.
Introduction
Cervical mediastinoscopy is a minimally invasive surgical
procedure for the biopsy of mediastinal lymph nodes for
diagnosis1 and for staging of known lung cancer.2 It
involves insertion of a mediastinoscope into the
mediastinum through a cervical incision under
anaesthesia. Biopsies of up to seven mediastinal lymph
node stations can be obtained on both sides of the
midline: 2, 4, 7 and 10 (Figure).
Accurate staging determines management of lung
cancer3 and predicts outcomes. Non-invasive tests for
identifying tumour metastases include chest X-ray,
computed tomography (CT) scanning and positron
emission tomography (PET) scanning. The latter has
reduced the need for mediastinoscopy in lung
cancer.1
Patients and Methods
The retrospective study was conducted at Aga Khan
University Hospital (AKUH), Karachi, and comprised
records of patients who underwent mediastinoscopy
between July, 1990 and August, 2015. Ethical approval
was obtained from the institutional review committee.
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Figure: The International Association for the Study of Lung Cancer (IASLC) lymph node
map.
Analysis was performed on SPSS 20. Frequencies and
percentages for categorical variables were calculated.
Mean and standard deviation for normally distributed
continuous variables and the median and interquartile
range (IQR) for skewed variables were computed. Chi
square was used to observe group differences. P<0.05 was
statistically significant.
Results
Of the 122 patients who had undergone
mediastinoscopy, 88(72%) cases had complete records
available and comprised the study sample. Mean age was
42.5±12.9 years and 55(62.5%) were male. Median length
of stay was 1 day (IQR: 1-16). Symptoms included fever,
cough, dyspnoea, chest pain and hoarseness. In 21
(23.8%) patients there was no symptom. Moreover,
60(69%) biopsies were taken from nodal station 2,
49(55.7%) from station 4, 37(42.0%) from station 7, and
3(3.4%) from station 10. Overall, 60(68.2%) patients had
benign inflammatory diseases; 25 (28.4%) had lymphoma
or lung cancer which was accurately staged; 26(29.5%)
had tuberculosis (TB); 13(14.8%) sarcoidosis; and 11
(12.5%) had concomitant TB and sarcoidosis. On frozen
section, 3(3.4%) cases were read as benign but were
found to be malignant on permanent sections. Among
the 25(28%) malignant cases, 21(84%) had bronchogenic
carcinoma (Table).
There was no mortality, serious complications or
transfusion.
Conclusion
Mediastinoscopy allows accurate information from
biopsies of lymph nodes. In our series, the majority
(68.2%) showed non-malignant granulomatous
diseases, predominantly TB 29.5%, sarcoidosis 14.8%,
and concurrent sarcoidosis and TB 12.5%. In the West,
83% are diagnosed with malignancy, of which 81%
have lung cancer.2 TB is now uncommon in the West.
Pakistan ranks 6th in the estimated global TB burden
list, with an incidence of 181/100000, and prevalence
359/100000.4
Sarcoidosis is a diagnostic challenge in countries whereTB
is endemic.5 The estimated prevalence of sarcoidosis in
this series was 27%, which seems higher than the West
(12%).2 A series from India reports 18%.1 In our study, the
prevalence of bronchogenic carcinoma was 24% and
lymphoma 4.5%. Eight (33.3%) of these had N0 and N1
disease and underwent resection of the primary tumours.
Thirteen (61.9%) were diagnosed with N2 or N3 disease
and were spared a resection. It is probably best to do
mediastinoscopy separately in an outpatient setting to
allow for reports of the more accurate permanent
sections.
Compared to the West, a very low proportion of
procedures were performed for staging of bronchogenic
carcinoma. The sensitivity and specificity of PET/CT for
lung cancer staging is lower than mediastinoscopy.6 PET-
negative nodes do have 10-15% incidence of containing
metastatic disease and biopsy should be considered
when the primary tumour is locally advanced or an
extended resection seems likely to be required for cure. In
Pakistan, the reliability of PET/CT may be lower due to TB
being endemic, likely increasing false positive rates.
Positive PET/CT may require histological confirmation.7
Moreover, on CT, enlarged nodes may be inflammatory
whereas normal-sized lymph nodes may contain
malignancy.8 Two patients had chemotherapy for
lymphoma and had PET-positive mediastinal lymph
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Table: Demographic and clinical characteristics of patients.
Variables n=88
Age in Years
-Mean (±SD) 42.5 (±12.9)
-Median (Min-Max) 44.5 (13-67)
Gender
-Male 55 (62.5)
-Female 33 (37.5)
Hospital Stay Days
-Mean (±SD) 2.7 (±3.1)
-Median (Min-Max) 1 (1-16)
Symptoms*
-Fever 30 (34.1)
-Dry to productive cough 22 (25.0)
-Dyspnea 16 (18.2)
-Chest pain 9 (10.2)
-Hoarseness of voice 5 (5.7)
-No symptoms 21 (23.8)
Clinical Findings
Mediastinal lymphadenopathy or mass 58 (65.9)
Known case of carcinoma/lymphoma 23 (26.1)
Suspected Sarcoidosis 3 (3.4)
Suspected TB 3 (3.4)
Suspected cases of TB and Sarcoidosis 1 (1.1)
Histopathological Diagnosis
Bronchogenic Carcinoma 21 (23.8)
Non-Hodgkin's lymphoma 2 (2.3)
Hodgkin's lymphoma 2 (2.3)
Tuberculosis (TB) 26 (29.5)
Sarcoidosis 13 (14.8)
Concurrent TB and Sarcoidosis 11 (12.5)
Benign reactive changes 7 (8.0)
Anthracosis or others 3 (3.4)
Unspecified 3 (3.4)
*More than one symptoms may be present in same patient.
SD: Standard Deviation.
nodes on follow-up. Biopsies revealed granulomatous
inflammation compatible with TB for which they were
treated. An assumption of recurrent lymphoma would
have led to further chemotherapy, with potentially
disastrous consequences.
Endobronchial ultrasound-transbronchial needle
aspiration (EBUS-TBNA) biopsy has reduced the need for
mediastinoscopy in lung cancer. These needle biopsies
are less effective in cases of lymphoma and granulomas as
they only provide cytology. The accuracy of mediastinal
lymph node biopsies by EBUS-TBNA for TB is 50%,
sarcoidosis 60%, but for lung cancer, it is 93%.9
Mediastinoscopy has advantage over video-assisted
thoracoscopic surgery (VATs) in the ability to biopsy both
sides, avoidance of double lumen endotracheal tubes,
chest tubes and hospitalisation. Complication rates are
minimal. Bleeding from vascular injuries like innominate
and pulmonary arteries and azygos vein, recurrent
laryngeal nerve injury, pneumothorax, tracheal or
oesophageal injury, pericardial puncture and wound
infection have rarely been reported.10
Mediastinoscopy is a safe procedure with minimal
morbidity and hospital stay. It is accurate in the staging
bronchogenic carcinoma as well as in the diagnosis of
other benign and malignant mediastinal pathologies. For
lung cancer staging, mediastinoscopy can often be
replaced by PET scanning and EBUS-TBNA. It still has
distinct advantage over these modalities in inflammatory
disease and lymphoma.
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